← Eichor
Study identifier: NCT06655272 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

OM 85 to Prevent Respiratory Infections in Older At Risk Patients

Condition: Respiratory Tract Infections (RTI)  ·  Sponsor: Campus Bio-Medico University

PhasePhase 4
Planned participants360
Who can joinAll sexes, 75 Years to no upper limit
Healthy volunteersNo

About this study

People living in NH are at higher risk of respiratory infections compared to their counterpart living in the community. Products obtained from dead bacteria ("bacterial lysate") can be used to boost immune system and may reduce the risk of respiratory infections. Very little information is available on the effect of these substances in older people. This study will evaluate the efficacy of a bacterial lysate in reducing the incidence of lower respiratory tract infections in older people living in nursing homes. The study will include a treatment arm, in which participants will received the lysate, and a control arm in which participants will received a matching placebo (i.e., a pill that has the same appearance of the lysate but does not contain the lysate itself).

This description comes directly from the study's public registry record.

Talk to the study team

Silvia Travaglini, MD  ·  +39 06 22541  ·  silvia.travaglini@unicampus.it

Always discuss trial participation with your own doctor first.

Locations (1)

Fondazione Policlinico Campus Bio-MedicoRoma, RM, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06655272